One-year clinical evaluation of 0.4% ripasudil (K-115) in patients with open-angle glaucoma and ocular hypertension. (Q54248457)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	One-year clinical evaluation of 0.4% ripasudil (K-115) in patients with open-angle glaucoma and ocular hypertension.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

One-year clinical evaluation of 0.4% ripasudil (K-115) in patients with open-angle glaucoma and ocular hypertension. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

open-angle glaucoma

1 reference

based on heuristic

inferred from title

8

object named as

Makoto Araie

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

author name string

Hidenobu Tanihara

1

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

Toshihiro Inoue

2

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

Tetsuya Yamamoto

3

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

Yasuaki Kuwayama

4

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

Haruki Abe

5

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

Atsuki Fukushima

6

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

Hideki Suganami

7

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

K-115 Clinical Study Group

9

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

publication date

4 September 2015

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

Acta Ophthalmologica

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

94

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

1

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

e26-34

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

Effects of K-115, a rho-kinase inhibitor, on aqueous humor dynamics in rabbits

1 reference

https://api.crossref.org/works/10.1111%2FAOS.12829

21 January 2018

The effect of Rho-associated protein kinase inhibitor on monkey Schlemm's canal endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FAOS.12829

21 January 2018

Delaying treatment of ocular hypertension: the ocular hypertension treatment study

1 reference

https://api.crossref.org/works/10.1111%2FAOS.12829

21 January 2018

Long-term brimonidine therapy in glaucoma patients with apraclonidine allergy.

1 reference

https://api.crossref.org/works/10.1111%2FAOS.12829

21 January 2018

Phase 2 randomized clinical study of a Rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertension

1 reference

https://api.crossref.org/works/10.1111%2FAOS.12829

21 January 2018

Phase 1 clinical trials of a selective Rho kinase inhibitor, K-115.

1 reference

https://api.crossref.org/works/10.1111%2FAOS.12829

21 January 2018

Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials

1 reference

https://api.crossref.org/works/10.1111%2FAOS.12829

21 January 2018

Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension

1 reference

https://api.crossref.org/works/10.1111%2FAOS.12829

21 January 2018

Ocular hypotensive effect of the Rho kinase inhibitor AR-12286 in patients with glaucoma and ocular hypertension

1 reference

https://api.crossref.org/works/10.1111%2FAOS.12829

21 January 2018

Identifiers

10.1111/AOS.12829

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26338317

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54248457&oldid=1878842479"